---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-002003"
form_type: "8-K"
ticker: "CCEL"
cik: "0000862692"
company_name: "CRYO CELL INTERNATIONAL INC"
filed_at: "2022-02-24T23:59:59+00:00"
generated_at: "2026-06-27T05:09:28.200110+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cryo-Cell reports FY2021 revenue $28.9M (-7% YoY), net income $2.1M (-42% YoY)

## Summary
- Revenue $28.9M, down 7% from $31.1M; processing/storage fees $28.4M vs $29.5M.
- Net income $2.1M ($0.26 basic EPS) vs $3.6M ($0.48 basic EPS) in FY2020.
- Public banking revenue fell to $376K from $727K; no licensee income vs $630K prior year.
- Recorded $1.2M public bank inventory impairment and $782K gain on contingent consideration.
- SG&A increased 2% while cost of sales decreased 7% YoY.

## SEC filing metadata
- accession: 0000950170-22-002003
- form_type: 8-K
- ticker: CCEL
- cik: 0000862692
- company_name: CRYO CELL INTERNATIONAL INC
- filed_at: 2022-02-24T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/862692/000095017022002003/0000950170-22-002003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/862692/000095017022002003/ccel-20220222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-002003
- JSON: https://secwatch.observer/filing/0000950170-22-002003.json
- Plain text: https://secwatch.observer/filing/0000950170-22-002003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.